STEM-11. DIRECTED NEURONAL DIFFERENTIATION AS A THERAPEUTIC STRATEGY FOR MALIGNANT GLIOMAS

IDH-mutant (IDH-MUT) glioma patients show highly improved prognosis compared to those with wild-type IDH. However, IDH mutations are rare in the more aggressive grade IV glioblastomas and introducing IDH mutations in mouse neural cells does not induce gliomagenesis. This is a paradox, given that IDH...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Audia, Alessandra, Ravikumar, Visweshwaran, Deng, Zhong, Murali, Vineeth, Balasubramaniyan, Veerakumar, de Groot, John, Rao, Arvind, Bhat, Krishna
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216192/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.1018
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi